Developer docs
API playgroundTry for free, no card

Search company profiles

Scinovia

Full company profile

uuid000afvw

Namestring
Scinovia
Websiteurl
scinovia.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Scinovia is a privately held medical technology company founded in 2014 and headquartered in Raleigh, North Carolina. It is developing a non-contact, real-time blood flow velocity measurement technology intended for use in surgical procedures, positioning it for the broader intra-operative imaging market spanning millions of surgeries annually. The company's core differentiator is delivering vessel blood flow speed data without physical contact with tissue, which would address workflow and sterility constraints in the operating room relative to invasive or contact-based alternatives.

The company operates with a small team (11-50 employees) led by CEO Jim Sund and Co-Founder & Head of Software Technology Jeff Haag. Across its history, Scinovia has disclosed three funding events totaling approximately $4.13 million (a ~$210K round in July 2014, a ~$3.8M round in December 2014, and a ~$112K tranche in December 2021); investor identities are not disclosed in the source data.

The business model cannot be precisely determined from the available data: no pricing model, customer segments, named customers, distribution channels, marketing channels, partnerships, regulatory clearances, or revenue figures are documented. Given the medical-device orientation and the modest capital base, plausible monetization paths would include direct sales or licensing of the sensing platform to hospitals and surgical centers, but this is inference rather than documented fact.

Short descriptiontext

Scinovia is a privately held Raleigh, NC-based medical technology company founded in 2014 that develops a non-contact, real-time blood flow velocity sensing technology for use during surgical procedures in hospitals and surgical centers.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRaleigh, United States
HQ citystring
Raleigh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
non-contact flow measurement, intraoperative blood flow imaging, vascular surgery diagnostics, real-time hemodynamic sensing, surgical measurement devices
Industry2 codes
PRIMARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Surgical Measurement and Imaging Devices
Social media profiles3 records
Cost components3 values
Technology or R&D, Personnel, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Scinovia develops a non-contact, real-time blood flow speed measurement device intended for use during vascular and related surgical procedures. The system is designed to deliver instantaneous hemodynamic readings in vessels without physically contacting the tissue, targeting millions of surgeries across hospital and surgical center settings.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Non-contact real-time blood flow speed measurement system
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medistim sells intraoperative transit-time flowmetry and imaging systems used during cardiac and vascular surgery, making it the closest direct competitor to Scinovia's non-contact blood-flow measurement device for surgical use.

TypeDirect peer
Description

Transonic manufactures transit-time ultrasound flow probes widely used in surgical and research blood-flow measurement, directly competing with Scinovia in the intraoperative vascular flow quantification market.

TypeDirect peer
Description

Moor Instruments specializes in laser Doppler flowmetry and microvascular blood-flow measurement, overlapping with Scinovia's non-contact real-time blood-flow measurement approach for clinical and research use.

TypeDirect peer
Description

Perimed develops laser-based perfusion and microcirculation measurement systems, directly comparable to Scinovia in the non-contact, real-time vascular flow measurement category.

TypeEmerging player
Description

Compumedics supplies surgical monitoring and neurological blood-flow measurement tools, providing partial overlap with Scinovia's intraoperative vascular assessment focus.

6Cook Medical
TypeBroad incumbent
Description

Cook Medical is a broad surgical and vascular device incumbent whose intraoperative vascular assessment products overlap with Scinovia's surgical blood-flow measurement value proposition.

TypeBroad incumbent
Description

GE HealthCare's surgical imaging and intraoperative ultrasound portfolio addresses the same surgical decision-making workflow that Scinovia's blood-flow measurement targets, but at much greater scale.

TypeBroad incumbent
Description

Philips offers intraoperative imaging, hemodynamic monitoring, and vascular assessment solutions relevant to the surgical workflow Scinovia's non-contact flow technology is designed to enhance.

TypeBroad incumbent
Description

Stryker's broad surgical and visualization portfolio includes intraoperative imaging tools adjacent to Scinovia's positioning, making it a relevant incumbent comparable for surgical workflow technologies.

TypeBroad incumbent
Description

Intuitive Surgical's da Vinci platform is a benchmark for computer-assisted surgery in which real-time intraoperative measurement (such as blood flow) is a logical add-on capability, similar in concept to Scinovia's targeted use case.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Scinovia

Surgical Measurement and Imaging Devicesscinovia.com

Scinovia is a privately held Raleigh, NC-based medical technology company founded in 2014 that develops a non-contact, real-time blood flow velocity sensing technology for use during surgical procedures in hospitals and surgical centers.

What Scinovia does

Scinovia is a privately held medical technology company founded in 2014 and headquartered in Raleigh, North Carolina. It is developing a non-contact, real-time blood flow velocity measurement technology intended for use in surgical procedures, positioning it for the broader intra-operative imaging market spanning millions of surgeries annually. The company's core differentiator is delivering vessel blood flow speed data without physical contact with tissue, which would address workflow and sterility constraints in the operating room relative to invasive or contact-based alternatives.

The company operates with a small team (11-50 employees) led by CEO Jim Sund and Co-Founder & Head of Software Technology Jeff Haag. Across its history, Scinovia has disclosed three funding events totaling approximately $4.13 million (a ~$210K round in July 2014, a ~$3.8M round in December 2014, and a ~$112K tranche in December 2021); investor identities are not disclosed in the source data.

The business model cannot be precisely determined from the available data: no pricing model, customer segments, named customers, distribution channels, marketing channels, partnerships, regulatory clearances, or revenue figures are documented. Given the medical-device orientation and the modest capital base, plausible monetization paths would include direct sales or licensing of the sensing platform to hospitals and surgical centers, but this is inference rather than documented fact.

Scinovia firmographics

Firmographics
Name
Scinovia
Website
https://scinovia.com
Company type
Private
Founded year
2014
Headcount range
11–50 employees
Short description
Scinovia is a privately held Raleigh, NC-based medical technology company founded in 2014 that develops a non-contact, real-time blood flow velocity sensing technology for use during surgical procedures in hospitals and surgical centers.
Ownership category
akta.pro rank

Scinovia industry classification

Industry
Product category
Surgical Measurement and Imaging Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Non-contact flow measurement
  • Intraoperative blood flow imaging
  • Vascular surgery diagnostics
  • Real-time hemodynamic sensing
  • Surgical measurement devices

Where Scinovia is headquartered

Location

Headquarters

HQ city
Raleigh
HQ country
United States
HQ region
North America

Markets served

Scinovia business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations

Scinovia product offering

Product offering

Core offering

Scinovia develops a non-contact, real-time blood flow speed measurement device intended for use during vascular and related surgical procedures. The system is designed to deliver instantaneous hemodynamic readings in vessels without physically contacting the tissue, targeting millions of surgeries across hospital and surgical center settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Non-contact real-time blood flow speed measurement system

Companies that use Scinovia

Customer profile

Ideal customer profiles1 record

Scinovia technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Scinovia partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights2 records

Scinovia competitors and assessment

Company assessment

Direct peers

  • Medistim: Medistim sells intraoperative transit-time flowmetry and imaging systems used during cardiac and vascular surgery, making it the closest direct competitor to Scinovia's non-contact blood-flow measurement device for surgical use.
  • Transonic Systems: Transonic manufactures transit-time ultrasound flow probes widely used in surgical and research blood-flow measurement, directly competing with Scinovia in the intraoperative vascular flow quantification market.
  • Moor Instruments: Moor Instruments specializes in laser Doppler flowmetry and microvascular blood-flow measurement, overlapping with Scinovia's non-contact real-time blood-flow measurement approach for clinical and research use.
  • Perimed AB: Perimed develops laser-based perfusion and microcirculation measurement systems, directly comparable to Scinovia in the non-contact, real-time vascular flow measurement category.

Emerging players

  • Compumedics: Compumedics supplies surgical monitoring and neurological blood-flow measurement tools, providing partial overlap with Scinovia's intraoperative vascular assessment focus.

Broad incumbents

  • Cook Medical: Cook Medical is a broad surgical and vascular device incumbent whose intraoperative vascular assessment products overlap with Scinovia's surgical blood-flow measurement value proposition.
  • GE HealthCare: GE HealthCare's surgical imaging and intraoperative ultrasound portfolio addresses the same surgical decision-making workflow that Scinovia's blood-flow measurement targets, but at much greater scale.
  • Philips: Philips offers intraoperative imaging, hemodynamic monitoring, and vascular assessment solutions relevant to the surgical workflow Scinovia's non-contact flow technology is designed to enhance.
  • Stryker: Stryker's broad surgical and visualization portfolio includes intraoperative imaging tools adjacent to Scinovia's positioning, making it a relevant incumbent comparable for surgical workflow technologies.
  • Intuitive Surgical: Intuitive Surgical's da Vinci platform is a benchmark for computer-assisted surgery in which real-time intraoperative measurement (such as blood flow) is a logical add-on capability, similar in concept to Scinovia's targeted use case.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Scinovia social profiles

Digital presence

Scinovia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Scinovia leadership team

Management profile

Number of profiles

Profiles2 records

Scinovia funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Scinovia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Scinovia

What does Scinovia do?

Scinovia develops a non-contact, real-time blood flow speed measurement device intended for use during vascular and related surgical procedures. The system is designed to deliver instantaneous hemodynamic readings in vessels without physically contacting the tissue, targeting millions of surgeries across hospital and surgical center settings.

When was Scinovia founded?

Scinovia was founded in 2014. It employs 11 to 50 people.

Where is Scinovia based?

Scinovia is headquartered in Raleigh, United States, in the North America region.

Who are Scinovia's main competitors?

Direct peers on record are Medistim, Transonic Systems, Moor Instruments and Perimed AB. Compumedics is listed as an emerging player. Broad incumbents are Cook Medical, GE HealthCare, Philips, Stryker and Intuitive Surgical.

Does Scinovia have an API?

No public API is recorded for Scinovia.

What industry is Scinovia in?

Scinovia's product category is Surgical Measurement and Imaging Devices. Its primary akta.pro industry code is HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT), with a secondary code of HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooThis Company is Revolutionizing Blood Flow Visualization During SurgeryScinovia, founded by Jim Sund, developed VUFLOW, a mobile imaging system for real-time, non-contact blood flow visualization during surgery. The company reports that visualizing blood flow reduced tissue death in breast reconstruction from 14% to 6%, saving about $100K per case. VUFLOW R will integrate Kuka's robotic arm for automated targeting.AccesswireThis Company is Revolutionizing Blood Flow Visualization During SurgeryScinovia introduced VUFLOW, a non-contact imaging system for real-time blood flow visualization during surgery. The company plans first-in-human studies in 2022 to validate its ability to predict tissue death, with a market launch expected after those trials.SecSEC FORM DScinovia Corp filed a Form D with the SEC to report an exempt securities offering under Rule 506(b). The company raised a total of $3,806,362 from 56 investors, including 35 non-accredited investors. The filing was signed by President Jim Sund on November 8, 2021.SecSEC FORM DScinovia Corp filed a Form D with the SEC regarding an exempt securities offering under Rule 506(b). The company has sold $3,806,362 USD of equity securities to 56 investors since the first sale on September 22, 2014. This filing serves as a regulatory notice of the ongoing capital raising activity.SecSEC FORM DScinovia Corp filed a Form D with the Securities and Exchange Commission for an exempt offering of securities under Rule 506(b). The filing indicates that $3,610,000 has been sold to 50 investors, including 34 non-accredited investors, with a minimum investment of $5,000. The first sale occurred on September 22, 2014, and the company estimates $200,000 of gross proceeds will be used for payments to executive officers or directors.